Varda Space Industries
Microgravity-enabled life-sciences company operating W-Series free-flying orbital platforms that process pharmaceutical active ingredients and materials in orbit and return product to Earth. Also serves as a hypersonic testbed for reentry and orbital flight testing.
FINANCIAL HEALTH
CAPITAL & CREDIT PROFILE
Source: USAspending.gov award obligations matched to this company. Obligations, not recognized revenue.
SECTOR POSITION
RECENT COVERAGE
| Date | Source | Headline |
|---|---|---|
| Oct 20, 2026 | NASASpaceFlight | Launch Preview: H3, Falcon 9, Electron, and others to launch during busy week |
| Oct 20, 2026 | NASASpaceFlight | Falcon 9 launches Bandwagon-5 rideshare mission from Florida |
| Oct 18, 2026 | NASASpaceFlight | Falcon 9 set to launch Bandwagon-5 rideshare mission from Florida |
| Oct 18, 2026 | Spaceflight Now | Live coverage: SpaceX to launch Starfall reentry capsule, 31 customer payloads on Bandwagon-5 rideshare mission |
| Oct 18, 2026 | Spaceflight Now | SpaceX launches Starfall reentry capsule, 31 customer payloads on Bandwagon-5 rideshare mission |
REGISTRY DATA
Source: space_company_registry.json · Operator homepage → · Corporate homepage (El Segundo, CA HQ; 2026 copyright) documents Varda's microgravity-enabled life-sciences platform and W-Series reentry missions through W-6, establishing operator status in the phar
METHODOLOGY
Launch history and subsystem outcomes aggregate from AstraVeris's launch_events table with Wilson 95% lower bounds on success rates. ARI scores come from the 11-factor composite (/finance/methodology/). Constellation counts derive from the live CelesTrak/GCAT object catalog. Gov contracts from USAspending.gov awards; private deals from deduplicated pipeline deal extraction. Absence of a row means "not tracked" — we never fabricate. See /methodology/ for the full data model and /data-licensing/ for licensing terms.
Not investment advice. For insurance underwriting, verify against primary-source filings and operator investigation reports.